VC firm
Ysios Capital
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Founded
- 2008
- Assets under management
- $500MStated by firm, as of 2026-09-17Source (opens in a new tab)
- Legal name
- Ysios Capital Partners SGEIC, S.A.
- ysioscapital.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Team page (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
We are a leading life sciences investor financing highly innovative companies worldwide.
Investment approach
- Thesis
- At Ysios Capital, the management team and strength of science of each venture are key to our investment thesis. We invest in companies bringing life-changing treatments to patients, with a focus on indications with high unmet need.Source (opens in a new tab)
- Eligibility
- We welcome submissions from life sciences companies developing innovative and transformative therapeutics.
- Traction requirement
- We seek drug candidates built on strong scientific foundations, backed by preclinical models or initial clinical data.
- Investing status notes
- Ysios Capital launches InceptionBio, a €100M fund to drive biotech company creation
Locations
- Office
- Barcelona, Spain
- Office
- San Sebastián, Spain
Programs
- Newsletter
- newsletter (opens in a new tab)
Loading relationship preview